*Jianshe Wei1, Baozhu Fan1,2, Yan Shi1, Mengying Zhang1, Riffat Jabeen1, Bing Bo1,2, Hui Zhang2, Makoto Hashimoto3 (1. Institute for Brain Sciences Research, Henan University, 2. School of Physical Education, Henan University, 3. Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, JAPAN)
Session information
Oral
[1O10m-1] Parkinson's Disease
Wed. Jul 29, 2020 9:00 AM - 10:00 AM Room 10
*Videos are available throughout the meeting period.
*HIRONORI KAWAHARA1,2, Tatsusada Okuno3, Tetsuo Yasugi4, Makoto Sato4, Yohei Shinmyo5, Hiroshi Kawasaki5, Hideki Mochizuki3, Rikinari Hanayama1,2 (1. Dept immunology, Kanazawa University, Ishikawa, Japan, 2. WPI NanoLSI, Kanazawa University, Ishikawa, Japan, 3. Dept of Neurology, Osaka University, Osaka, Japan, 4. Dept of Devl Neurobiol, Kanazawa University, Ishikawa, Japan, 5. Dept of Medical Neurosci, Kanazawa University, Ishikawa, Japan)
*JIRO KASAHARA1, Masatoshi Ogawa1, Yu Zhou1, Ryosuke Tsuji1, Satoshi Goto1,2 (1. Dept Neurobiol Therapeu, Inst Biomed Sci, Grad Sch Pharmaceu Sci, Tokushima Univ, 2. Dept Neurodeg Dis Res, Inst Biomed Sci, Tokushima Univ)
*Akito Hattori1, Etsuro Ohta2,3,4,5, Makiko Nagai6, Hiroyuki Miyoshi5, Kazuya Iwabuchi1, Hideyuki Okano5 (1. Program in Cellular Immunol, Gradu Sch Med Sci Kitasato Univ, Kanagawa, Japan, 2. Div Clinical Immunol, Gradu Sch Med Sci Kitasato Univ, Kanagawa, Japan, 3. Dept Immunol2, Kitasato Univ of Allied Health Sci, Kanagawa, Japan, 4. R&D center for Cell Design, Institute for Regenerative Medicine and Cell Design, Kitasato Univ, Kanagawa, Japan, 5. Keio Univ Sch Med, Tokyo, Japan, 6. Dept Neurol, Kitasato Univ Sch of Med, Kanagawa, Japan)